Phase 2 N=12 Treating Respiratory Emergencies in Children Study
Asthma in Children
Primary: Proportion of Patients Admitted to the Hospital in Each Group — 6; 15 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=248 Improving Screening and Therapy for Hispanic/Latinx at Risk for CKD
Type 2 Diabetes · Chronic Kidney Diseases
Primary: Number of Participants Who Attended or Scheduled a Primary Care Physician (PCP) Visit — 14 Participants
Phase 2 N=107 (PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis
Advanced Systemic Mastocytosis · Aggressive Systemic Mastocytosis · Systemic Mastocytosis With an Associated Hematologic Neoplasm
Primary: Overall Response Rate (ORR) Based on Modified International Working Group-Myeloproliferative Neoplasms Research and Treatment and European Competence Network on…
Phase 3 N=41 A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection
Clostridium Difficile Infection Recurrence
Primary: Number of Participants With RBX2660-related Treatment-emergent Adverse Events (TEAEs) After RBX2660 Treatment Delivered by Colonoscopy Through 8 Weeks, or Treatment…
Phase 2 N=62 Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant
Acute Myeloid Leukemia
Primary: Feasibility of Successfully Generating CIML NK Cells With Standard of Care (SOC) DLI From the Original Stem Cell Donor as Measured by the Number of Participants That Had…
N/A N=446 Thoraco Lumbar Vertebral Length and Bupivacaine Dosage in C-Section
Obstetric Anesthesia Problems · Bupivacaine Adverse Reaction
Primary: Hypotension Rate Among the Groups — 9; 26; 37 Participants
N/A N=43 Treatment of Adult Traumatic Rib Fractures With Percutaneous Cryoneurolysis
Rib Fractures
Primary: Daily Numeric Pain Score — 7.48; 6.47 score on a scale — p=0.2228
N/A N=76 InformationSeekingMesolimbicEngagementStudy1
Motivation
Primary: Mesolimbic-hippocampal Interactions — .153; .150 standardized beta-value — p==.09
N/A N=33 Dose, Safety, and Pathogenicity of a New Influenza A H3N2 Challenge Strain
Influenza A H3N2
Primary: Occurrence of Adverse Events Related to the Viral Challenge — 0; 0; 1; 6 Occurrence of adverse events
Phase 2 N=279 Evaluation of the Efficacy and Safety of LevoCept
Contraception
Primary: Contraceptive Efficacy Through During LevoCept Use — 0; 0; 0 Pregnancies per 100 woman-years
Phase 2 N=18 Crizanlizumab for Treatment of Retinal Vasculopathy With Cerebral Leukoencephalopathy (RVCL)
RVCL - Retinal Vasculopathy Cerebral Leukoencephalopathy
Primary: Change in the Percentage of White Matter Hyperintensity (WMH) Lesion Volume on FLAIR MRI in RVCL Patients — 31.3 Percent (%)
Phase 2 N=354 Praziquantel in Children Under Age 4
Schistosomiasis · Schistosomiasis Mansoni · Schistosoma Japonicum Infection
Primary: Treatment Efficacy — 96; 98; 96; 98 percentage change
Early Phase 1 N=15 DEXTENZA in Pediatric Patients Following Retinal Surgery or Laser Treatment Under Anesthesia
Vitreoretinopathy · Coats' Disease · Exudative Retinopathy
Primary: Pain as Measured by the FLACC Pain Scale — 0; 0; 0; 0 score on a scale — p=0.3046
Phase 4 N=45 Denosumab (DMAB) Discontinuation And Switching In Glucocorticoid-Induced Osteoporosis (GIOP): A Pilot Study
Osteoporosis
Primary: Absolute Difference in the Log-transformed CTX Values Between V4 vs. V6 — 129.15; 71.79; 107.62 log (ng/mL)
Phase 3 N=1,407 A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP)
Obesity
Primary: Semaglutide 7.2 mg Versus Placebo: Relative Change in Body Weight — -19.5; -3.8 Percentage (%) change in body weight — p=<0.0001